View in EDS HTML Full Text PDF Full Text

A real-world pharmacovigilance study of abaloparatide based on the FDA Adverse Event Reporting System (FAERS).

Saved in:
Bibliographic Details
Title: A real-world pharmacovigilance study of abaloparatide based on the FDA Adverse Event Reporting System (FAERS).
Authors: Shi, X.1, Cheng, Q.1, Zhao, Y.-Z.1, Zou, S.-P.1, Sun, M.-H.1 Smh007tj@163.com
Source: Osteoporosis International. Dec2023, Vol. 34 Issue 12, p2047-2058. 12p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:0937941X
DOI:10.1007/s00198-023-06877-6